Compositions: ceramic – Ceramic compositions
Reexamination Certificate
2006-08-08
2006-08-08
Group, Karl (Department: 1755)
Compositions: ceramic
Ceramic compositions
C623S023500, C623S023560
Reexamination Certificate
active
07087540
ABSTRACT:
The invention relates to a resorbable bone replacement and bone formation material (augmentation material) based on porous β-tricalcium phosphate (β-TCP).
REFERENCES:
patent: 4195366 (1980-04-01), Jarcho et al.
patent: 5096814 (1992-03-01), Aivasidis et al.
patent: 5141510 (1992-08-01), Takagi et al.
patent: 5531794 (1996-07-01), Takagi et al.
patent: 6340648 (2002-01-01), Imura et al.
patent: 6383519 (2002-05-01), Sapieszko et al.
patent: 6511510 (2003-01-01), de Bruijn et al.
patent: 6521246 (2003-02-01), Sapieszko et al.
patent: 2003/0049328 (2003-03-01), Dalal et al.
patent: 2003/0171822 (2003-09-01), Lo
patent: 2004/0019385 (2004-01-01), Ayers et al.
patent: 2004/0064194 (2004-04-01), Irie et al.
patent: 3123460 (1982-02-01), None
patent: 3810803 (1989-10-01), None
patent: 3810803 (1989-10-01), None
patent: 1-108143 (1989-04-01), None
DeGroot, Ph.D., Klaas (Editor); “Bioceramics of Calcium Phosphate”,CRC Press, Inc., Boca Raton, Florida (1983).
Meachim, G., Brooke G. and Pedley, R.B., “The tissue response to acrylic particles Implanted in animal muscle”;Biomaterials 1982, vol. 3 Oct.; pp. 213-219.
Sjoholm, Ingvar and Edman, Peter; “Acrylic Microspheres In Vivo. I. Distribution and Elimination of Polyacrylamide Microparticles after Intravenous and Intraperitoneal Injection in Mouse and Rat”,The Journal of Pharmacology and Experimental Therapeutics, vol. 211, No. 3 (1979), pp. 656-662.
Klawitter, J.J., Bagwell, J.G., Weinstein, A.M. Sauer, B.W.; “An Evaluation of Bone Growth into Porous High Density Polyethylene”,J. Biomed. Mater. Res., vol. 10 (1976), pp. 311-323.
DeGroot et al.,Die klinische anwendbarkeit von Calciumphosphat-Keramiken, Zahnarztliche Mitteilungen Heft 18/65. 75, Jahrgang (1985, pp. 1938-1940.
Roempp Chemie-Lexikon ed. 7 (1975, Franckhsche Verlagsbuchhaltung Stuttgart.
Koster, K. Helde H. Konig R., Histologische Untersuchungen an der Grenzflache zwischen Knochengewebe und Calciumphosphat-, Calciumaluminat- und Aluminiumoxidkeramik, Z. Orthop. 115 (1977), pp. 693-699.
Erbe et al.,Comparison of Vitoss and Pro Osteon 500R in a Canine Model at 1 Year, 47thAnnual Meeting, Orthopaedic Research Society (Feb. 25-28, 2001), p. 0975.
510(k)Summary Vitoss™ Scaffold Synthetic Cancellous Bone Void Filler, Summary of S&E, Vitoss Scaffold, Orthovita. Inc. (Dec. 14, 2000) pp. H1-H3.
Letter from Dept. of Health & Human Services re:Vitoss™ Scaffold Synthetic Cancellous Bone Void Filler(Dec. 14, 2000), 2 pages.
Indications for Use Statement,Vitoss™ Scaffold Synthetic Cancellous Bone Void Filler, Vitoss Scaffold 510(k) Notification (Dec. 7, 2000) 1 page.
510(k)Summary(Nov. 26, 2002) 2 pages.
Galols et al.Use of β-tricalcium phosphate in foot and ankle surgery: a report of 20 cases, Blackwell Science Ltd., Foot and Ankle Surgery Dec. 2001 7:217-227.
Filling of Bone Defects with Tricalcium Phosphate Beta in Traumatology, In Ann Chir Dec.; 2000 125(10):972-81 (concise statement).
PCT International Search Report, International Application No. PCT/EP 00/ 08382 filed Aug. 28, 2000.
Dinkelaker Albrecht
Heide Helmut
Pabst Joachim
Pobantz Olaf
curasan AG
Group Karl
Myers Bigel & Sibley Sajovec, PA
LandOfFree
Resorbable bone replacement and bone formation material does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Resorbable bone replacement and bone formation material, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Resorbable bone replacement and bone formation material will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3620984